Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank43
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P43
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2024-5.58%
2023-28.68%
202242.05%
202121.07%
2020468.93%
2019-21.62%
2018-18.80%
2017-18.61%
2016-15.27%
2015251.27%